Zoetis inc stock.

The estimated Net Worth of Gregory Norden is at least $9.81 Million dollars as of 17 June 2023. Mr. Norden owns over 14,851 units of Zoetis Inc stock worth over $8,091,578 and over the last 10 years he sold ZTS stock worth over $1,360,615. In addition, he makes $355,000 as Independent Director at Zoetis Inc.ZOETIS INC is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying …The firm owned 34,949 shares of the company’s stock after acquiring an additional 24,714 shares during the quarter. 1832 Asset Management L.P.’s holdings in Zoetis were worth $6,019,000 as of ...Astorga Ferran ZTS stock SEC Form 4 insiders trading. Astorga has made over 1 trades of the Zoetis Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Astorga exercised 308 units of ZTS stock worth $50,256 on 30 September 2023.. The largest trade Astorga's ever made was exercising 308 units of …

Zoetis Declares Fourth Quarter 2023 Dividend. PARSIPPANY, N.J., October 12, 2023--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the fourth ... View Zoetis Inc ZTS investment & stock information. Get the latest Zoetis Inc ZTS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Zoetis shares rose 5.4% on Tuesday after Q4 2022 results showed its growth back on track. The P/E is now back to 35x. See why ZTS stock is a buy.View the latest Zoetis Inc. (ZTS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Zoetis is forecast to grow earnings and revenue by 8.6% and 7% per annum respectively. EPS is expected to grow by 9.1% per annum. Return on equity is forecast to be 46.3% in 3 years.Shares of Zoetis stock traded down $1.45 during trading hours on Tuesday, reaching $177.34. 222,256 shares of the stock traded hands, compared to its average volume of 1,952,788. Zoetis Inc. has a ...Analyst Report: Zoetis Inc Find the latest Zoetis Inc. (ZTS) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance. Nov 13, 2023. finance.yahoo.com . Zoetis Inc. (ZTS) Q3 2023 Earnings Conference Call TranscriptFDA nod for NexGard Plus. Animal health company Zoetis Inc. ( NYSE: ZTS) traded higher Friday as analysts commented on the FDA approval of German drugmaker Boehringer Ingelheim's parasiticide ...See Best Monthly Dividend Stocks Model Portfolio for our top monthly income ideas. Growth Goal. ZTS. Target. Market- ...

What is Zoetis Inc (ZTS)'s stock price today? The current price of ZTS is $175.79. The 52 week high of ZTS is $194.99 and 52 week low is $140.76. When is next earnings date of Zoetis Inc (ZTS)?

The stock of Zoetis Inc (ZTS) has gone up by 3.52% for the week, with a 7.35% rise in the past month and a -3.00% drop in the past quarter. The volatility ratio for the week is 2.00%, and the volatility levels for the past 30 days are 2.50% for ZTS. The simple moving average […]

Zoetis is a component of the S&P 500 and has roughly 13,800 employees. Analyst Report: Zoetis Inc Zoetis Inc., a 2013 spinoff from Pfizer, focuses on the development, manufacture and ...The estimated Net Worth of Paul Bisaro is at least $37.6 Milión dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,215,457 and over the last 11 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Read Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ...Zoetis shares fell 11% on the day of Q3 results, as investors reacted to a 3.7% decline in its Adjusted EPS. See why we reiterate our buy rating on ZTS stock.Get the latest Zoetis Inc (ZOE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

ZOETIS INC is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the stock’s valuation.ZOETIS INC is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the stock’s valuation.Read Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ...PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2021 and increased its guidance for full year 2021. The company reported revenue of $2.0 billion for the third quarter of 2021, an increase of 11% compared with the third quarter of 2020.Michael has made over 37 trades of the Zoetis Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 1,626 units of ZTS stock worth $273,379 on 11 February 2023.Apr 20, 2023 · At Zoetis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

Zoetis Declares Fourth Quarter 2023 Dividend October 12, 2023. Zoetis Named a 100 Best Company for Working Parents by Seramount October 10, 2023. Zoetis to Host Webcast and Conference Call on Third Quarter 2023 Financial Results September 27, 2023. Zoetis Foundation Announces $2.6 Million in Grants to Advance Opportunities for …

Zoetis Declares Fourth Quarter 2023 Dividend. PARSIPPANY, N.J., October 12, 2023--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the fourth ... The Dividend Yield % of Zoetis Inc (ZTS) is 0.84% (As of Today), Highest Dividend Payout Ratio of Zoetis Inc (ZTS) was 0.3. The lowest was 0.16. And the median was 0.19. The Forward Dividend Yield % of Zoetis Inc (ZTS) is 0.84%. For more information regarding to dividend, please check our Dividend Page . 47 minutes ago. Company profile page for Zoetis Inc including stock price, company news, press releases, executives, board members, and contact information.Headquartered in Parsippany, New Jersey, Zoetis Inc. (NYSE:ZTS) is an animal health medicines, vaccines, and diagnostic products manufacturer. On February 28, 2023, Zoetis Inc. (NYSE:ZTS) stock ...Investors are eagerly awaiting Zoetis Inc’s upcoming earnings report, scheduled to be released on August 8. This report will provide further insights into the company’s financial performance and may impact the stock’s future trajectory. Overall, Zoetis Inc’s stock performance on July 3, 2023, indicates a positive outlook for the …Zoetis Inc. (ZTS) Stock Price, Quote, News & Analysis Black Friday is here! Save 45% on Premium AND Alpha Picks now » ZTS Zoetis Inc. Stock Price & Overview …Stefan Weiskopf ZTS stock SEC Form 4 insiders trading. Stefan has made over 1 trades of the Zoetis Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Stefan bought 320 units of ZTS stock worth $9,965 on 31 January 2013.. The largest trade Stefan's ever made was buying 320 units of Zoetis Inc stock on …The estimated Net Worth of Gregory Norden is at least $5.83 Million dollars as of 7 March 2023. Mr. Norden owns over 12,500 units of Zoetis Inc stock worth over $4,114,068 and over the last 10 years he sold ZTS stock worth over $1,360,615. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Zoetis Inc. (NYSE:ZTS) posted its quarterly earnings data on Tuesday, August, 8th. The company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.31 by $0.10. The business earned $2.18 billion during the quarter, compared to the consensus estimate of $2.16 billion.ZTS Análisis Financiero de Acciones - Zoetis Inc - Class A (NYSE) Stock.

Zoetis Inc (ZTS) stock is higher by 1.08% while the S&P 500 is lower by -0.02% as of 2:56 PM on Thursday, Nov 16. ZTS has risen $1.88 from the previous closing price of $174.57 on volume of 644,884 shares. Over the past year the S&P 500 has risen 13.72% while ZTS has risen 19.00%. ZTS earned $4.92 a per share in the over the last 12 months ...

Zoetis Inc. (NYSE: ZTS) today announced the completion of the acquisition of Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83 per share in cash, or approximately $2.0 billion in aggregate.

US98978V1035. Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. Benefits. Revolution Plus is the most prescribed medicine for feline parasite protection1. Building on the legacy of Revolution® (selamectin), Revolution Plus is now the trusted choice. Revolution Plus is an all-in-one solution—one application a month defends against roundworms, hookworms, and heartworm disease plus has a unique dual action ... April 30, 2020. Launched by leading animal health company Zoetis. Uniquely combines preventive care with best-in-class health insurance for dogs and cats. NEW YORK-- ( BUSINESS WIRE )-- Pumpkin Insurance Services , Inc. (“Pumpkin”), a new pet insurance agency and pet care company, announced today the launch of its new insurance and …On 2023-11-30, Zoetis Inc (ZTS-N) stock closed at a price of $176.67. You may also like: RBI-T TYG-N MGT-T PBI-N BCPC-Q XST-T TARO-Q CRDF-Q JRCC-Q AKG-T Your Watchlist Add stocks to watchlist to monitor them daily and get important alerts. Get Access To Watchlist Get Access To Watchlist Latest ...PARSIPPANY, N.J.--(BUSINESS WIRE)-- Today, the Zoetis Foundation announced that it will distribute $2.6 million during its second round of 2023 grants, supporting six initiatives to help enable thriving professions and livelihoods for livestock farmers and veterinary professionals. The Zoetis Foundation has selected grantees that …“With Zoetis’ global sales and regulatory expertise in more than 45 markets, we look forward to expanding the impact and reach of the entire Jurox portfolio.” Jurox develops and manufactures more than 150 products in areas such as parasiticides, anti-infectives, anaesthesia, cardiology and reproduction for animals. About ZoetisFind the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.Dec 4, 2023 · Read Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ... As pet owners, we want to keep our furry friends safe and secure. Invisible Fence Inc. has been providing pet owners with innovative solutions to keep their pets out of harm’s way for over 40 years. With their advanced technology, Invisible...Latest news about Zoetis Inc. Transcript : Zoetis Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-28-2023 01:00 PM. Nov. 28. CI. Zoetis Insider Sold Shares Worth $2,298,856, According to a Recent SEC Filing. Nov. 21. MT. Zoetis Insider Sold Shares Worth $163,796, According to a Recent SEC Filing.Corporate Overview. As the world’s leading animal health company, Zoetis exists to nurture our world and humankind by advancing care for animals. With 70 years of experience innovating a leading portfolio and pipeline of medicines, vaccines, diagnostics, and technologies, we stand by those caring for animals by providing solutions worldwide.Zoetis Company Info. Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and ...

Sep 30, 2022 · PARSIPPANY, N.J. & RUTHERFORD, New South Wales, Australia--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today announced it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide range of veterinary medicines for treating livestock and companion animals. Dec 4, 2023 · Read Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ... The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.325 per share for the third quarter of 2022. The dividend will be paid on Thursday, September 1, 2022, to all holders of record of the Company’s common stock as of the close of business on Thursday, July 21, 2022. About Zoetis As the world’s leading animal health company, Zoetis is driven by a singular purpose ...Instagram:https://instagram. vanguard dividend growth invbuy shares of artare goldbacks worth buyingtransportation stocks Nov 21, 2023 · Corporate Overview. As the world’s leading animal health company, Zoetis exists to nurture our world and humankind by advancing care for animals. With 70 years of experience innovating a leading portfolio and pipeline of medicines, vaccines, diagnostics, and technologies, we stand by those caring for animals by providing solutions worldwide. ffie stock forecastwrnt stock The estimated Net Worth of Willie M Reed is at least $3.36 million dollars as of 11 February 2023. Willie Reed owns over 1,626 units of Zoetis Inc stock worth over $1,618,120 and over the last 9 years he sold ZTS stock worth over $1,411,766. In addition, he makes $330,000 as Independent Director at Zoetis Inc.Read Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ... forex reviews At Zoetis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Zoetis shares rose 5.4% on Tuesday after Q4 2022 results showed its growth back on track. The P/E is now back to 35x. See why ZTS stock is a buy.175.79 Volume 14 Change -1.18 % Change -0.67% Today's Open 177.87 Previous Close 176.97 Intraday High 178.06 Intraday Low 175.24 52 Week High 194.99 …